MFADX
Price
$25.23
Change
-$0.12 (-0.47%)
Updated
Aug 15 closing price
Net Assets
90.03M
QLENX
Price
$18.55
Change
+$0.05 (+0.27%)
Updated
Aug 15 closing price
Net Assets
5.49B
Interact to see
Advertisement

MFADX vs QLENX

Header iconMFADX vs QLENX Comparison
Open Charts MFADX vs QLENXBanner chart's image
Cromwell Long Short Investor
Price$25.23
Change-$0.12 (-0.47%)
VolumeN/A
Net Assets90.03M
AQR Long-Short Equity N
Price$18.55
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets5.49B
MFADX vs QLENX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MFADX vs. QLENX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFADX is a Buy and QLENX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 5.49B vs. MFADX (90M). QLENX pays higher dividends than MFADX: QLENX (6.13) vs MFADX (0.86). MFADX was incepted earlier than QLENX: MFADX (13 years) vs QLENX (12 years). QLENX (5.59) is less costly to investors than MFADX (2.34). QLENX is a more actively managed with annual turnover of: 362.00 vs. MFADX (108.00). MFADX has a lower initial minimum investment than QLENX: MFADX (2000) vs QLENX (2500). QLENX annual gain was more profitable for investors over the last year : 29.71 vs. MFADX (13.73). QLENX return over 5 years is better than : 181.61 vs. MFADX (41.62).
MFADXQLENXMFADX / QLENX
Total Expense Ratio2.165.5839%
Annual Report Gross Expense Ratio2.345.5942%
Fund Existence13 years12 years-
Gain YTD11.73618.98762%
Front LoadN/AN/A-
Min. Initial Investment2000250080%
Min. Initial Investment IRAN/AN/A-
Net Assets90M5.49B2%
Annual Yield % from dividends0.866.1314%
Returns for 1 year13.7329.7146%
Returns for 3 years27.59104.2626%
Returns for 5 years41.62181.6123%
Returns for 10 years72.02143.6050%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECHSX12.780.14
+1.11%
Eaton Vance Worldwide Health Sci C
SCSMX23.60N/A
N/A
ClearBridge Small Cap Growth C
IEIFX11.01-0.02
-0.18%
Invesco Equity and Income R6
AMGCX10.04-0.02
-0.20%
Alger Mid Cap Growth C
NBRTX26.40-0.10
-0.38%
Neuberger Berman M/C Intrinsic Val Inst